Lobular carcinoma in situ

HY Wen, E Brogi - Surgical pathology clinics, 2018 - Elsevier
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular breast carcinoma and its variants

EA Rakha, IO Ellis - Seminars in diagnostic pathology, 2010 - Elsevier
Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation,
morphologic and molecular features, and clinical behavior, and its incidence is rising in …

NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy …

SE Pinder, A Shaaban, R Deb, A Desai, A Gandhi… - Clinical radiology, 2018 - Elsevier
Needle core biopsy is considered the histological diagnostic method of choice for screen-
detected breast lesions. Although the majority are definitively diagnosed as normal, benign …

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision

MP Murray, C Luedtke, L Liberman, T Nehhozina… - Cancer, 2013 - Wiley Online Library
BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy

MH Rendi, SM Dintzis, CD Lehman… - Annals of surgical …, 2012 - Springer
Background The surgical management of lobular in-situ neoplasia (LN) identified by core
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …

High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis

ND Forester, S Lowes, E Mitchell, M Twiddy - European Journal of Surgical …, 2019 - Elsevier
Introduction Provide evidence to support evolving management strategies for high-risk (B3)
breast lesions by assessing risk of carcinoma in subgroups of B3 lesions using systematic …

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy

MG Shah-Khan, XJ Geiger, C Reynolds… - Annals of surgical …, 2012 - Springer
Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium

TS Menes, R Rosenberg, S Balch, S Jaffer… - The American Journal of …, 2014 - Elsevier
Background Upgrade rates of high-risk breast lesions after screening mammography were
examined. Methods The Breast Cancer Surveillance Consortium registry was used to …

[HTML][HTML] Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision

MG Kuba, MP Murray, K Coffey, C Calle, M Morrow… - Modern Pathology, 2021 - Elsevier
Lobular carcinoma in situ (LCIS) is currently classified as classic (CLCIS), florid (FLCIS), and
pleomorphic (PLCIS). Given the rarity of FLCIS and PLCIS, information on their clinico …

Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective …

F Nakhlis, L Gilmore, R Gelman, I Bedrosian… - Annals of surgical …, 2016 - Springer
Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …